Akseli Hemminki

University of Helsinki

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (20)

Collaborators (9)

Otto Hemminki

University of Helsinki

Harri Kalevi Mustonen

University of Helsinki

Xinjun Li

Senior Lecturer

Lund University

Václav Liška

Charles University, Faculty of Medicine in Pilsen

CZECH REPUBLIC

Kari Hemminki

CZECH REPUBLIC

Jan Sundquist

Lund University

Inge Marie Svane

Københavns Universitet

Jianguang Ji

Lund University

Antti Rannikko

University of Helsinki

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Akseli Hemminki

Research Interests

Explore related searches

Contact this professor

Articles (20)

Collaborators (9)

Otto Hemminki

Harri Kalevi Mustonen

Xinjun Li

Václav Liška

Kari Hemminki

Jan Sundquist

Inge Marie Svane

Jianguang Ji

Antti Rannikko

Make your next move.

Akseli Hemminki

Research Interests

Explore related searches

Contact this professor

Articles (20)

Oncolytic adenovirus encoding variant interleukin-2 combined with chemotherapy enables PD-L1 inhibition in pancreatic cancer models

Familial risks and incidence rates for childhood nervous system tumors in Sweden

Boosting anti-tumor immunity with TILT-517 oncolytic adenovirus and checkpoint blockade in renal cell carcinoma

Safety and efficacy of combined treatment with tumor-infiltrating lymphocytes and oncolytic adenovirus TILT-123 in metastatic melanoma.

Sex specific familial risk in lung cancer through changing histologies in Sweden

Oncolytic adenoviruses in platinum-resistant ovarian cancer: a new era in immunotherapy?

Single-cell profiling of peripheral blood mononuclear cells from patients treated with oncolytic adenovirus TILT-123 reveals baseline immune status as a predictor of therapy outcomes

Lung cancer risk between maternal and paternal half-siblings points to main environmental causation and targets for prevention

High familial risks in some rare cancers may pinpoint to hidden germline genetics

Age-specific familial risks in cancer as clues to germline genetic and environmental causes

Population-Attributable Fractions of Personal Comorbidities for Liver, Gallbladder, and Bile Duct Cancers

Early mortality critically impedes improvements in thyroid cancer survival through a half century

Long-Term Periodic and Conditional Survival Trends in Prostate, Testicular, and Penile Cancers in the Nordic Countries, Marking Timing of Improvements

Conditional Survival in Prostate Cancer in the Nordic Countries Elucidates the Timing of Improvements

Conditional survival in breast cancer up to 10 years in the Nordic countries

Survival in Kidney and Bladder Cancers in Four Nordic Countries through a Half Century

Long‐term survival trends in solid cancers in the Nordic countries marking timing of improvements

Survival in Lung Cancer in the Nordic Countries Through A Half Century

Survival in gastric and esophageal cancers in the Nordic countries through a half century

Personal comorbidities and their subsequent risks for liver, gallbladder and bile duct cancers

Collaborators (9)

Otto Hemminki

Harri Kalevi Mustonen

Xinjun Li

Václav Liška

Kari Hemminki

Jan Sundquist

Inge Marie Svane

Jianguang Ji

Antti Rannikko

Make your next move.